ID: ALA2368379

Max Phase: Preclinical

Molecular Formula: C31H31N6NaO15

Molecular Weight: 728.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1nc(OCc2ccccc2)c2ncn([C@H]3C[C@H](O)[C@@H](CO)O3)c2n1)OCc1ccc(O[C@@H]2O[C@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H]2O)c([N+](=O)[O-])c1.[Na+]

Standard InChI:  InChI=1S/C31H32N6O15.Na/c38-10-19-17(39)9-20(50-19)36-13-32-21-26(36)33-30(34-27(21)48-11-14-4-2-1-3-5-14)35-31(45)49-12-15-6-7-18(16(8-15)37(46)47)51-29-24(42)22(40)23(41)25(52-29)28(43)44;/h1-8,13,17,19-20,22-25,29,38-42H,9-12H2,(H,43,44)(H,33,34,35,45);/q;+1/p-1/t17-,19+,20+,22-,23-,24+,25-,29+;/m0./s1

Standard InChI Key:  NTNDVDBYGYKTLX-HLBIFANBSA-M

Associated Targets(non-human)

Beta-glucuronidase 93 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-glucuronidase 291 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 728.62Molecular Weight (Monoisotopic): 728.1926AlogP: -0.03#Rotatable Bonds: 12
Polar Surface Area: 300.44Molecular Species: ACIDHBA: 18HBD: 7
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.70CX Basic pKa: 1.32CX LogP: 1.15CX LogD: -2.35
Aromatic Rings: 4Heavy Atoms: 52QED Weighted: 0.07Np Likeness Score: 0.34

References

1. Wei G, Loktionova NA, Pegg AE, Moschel RC..  (2005)  Beta-glucuronidase-cleavable prodrugs of O6-benzylguanine and O6-benzyl-2'-deoxyguanosine.,  48  (1): [PMID:15634019] [10.1021/jm0493865]

Source